Evidence map›Paper›PMID 35784539›Full record

ReviewFrontiers in endocrinology2022

Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.

Lijia Cui, Qian Li, Wenmin Guan, Wei Yu, Xiang Li, Weibo Xia, Yan Jiang

Open access · goldAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. A case of papilledema in Camurati-Engelmann disease treated effectively with prednisolone.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lijia CuiDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Qian LiDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Wenmin GuanDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Wei YuDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Xiang LiDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Weibo XiaDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Yan JiangDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Peking Union Medical College Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camurati-Engelmann Disease (CED) is a rare sclerosing bone disease, sometimes associated delayed puberty. The treatment effect of glucocorticoid and angiotensin II receptor blocker (ARB) in bone health and puberty development remain unclear. We report a case of an 18-year-old girl who presented for a history of an enlarged head, pain of lower limbs, and no menstrual onset or breast development. Radiographs revealed thickening of skull and cortices in the diaphysis but sparse bone trabeculae in the spine and metaphysis. Sanger sequencing detected a mutation of c. 652C>T (p. R218C) in the gene

Indexed as

Camurati-Engelmann SyndromeAdolescentAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBone DensityFemaleGlucocorticoidsHumansLosartanPainPubertyAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsGlucocorticoidsLosartanangiotensin receptor II blockerbone masshypogonadotropic hypogonadismprednisoneprogressive diaphyseal dysplasia

Identifiers

PMID35784539
PMCPMC9247158
OpenAlexW4283027776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.